- 36th:
-
Annual Meeting of the European Group for Blood and Marrow Transplantation
- 26th:
-
Meeting of the EBMT Nurses Group
- 9th:
-
Meeting of the EBMT Data Management Group
- 2nd:
-
EBMT Quality Management Meeting
Vienna, Austria, 21–24 March 2010
Correction to: Bone Marrow Transplant 45: S78–S327; doi:10.1038/bmt.2010.41
Since the publication of this paper, an error has been identified in abstract P723 located on pages S209–S210 entitled ‘Voriconazole or itraconazole for antifungal prophylaxis in patients with grade II-IV acute or extensive chronic graft-versus-host disease’.
The third sentence in the Results section currently reads: ‘Mean time to first report of GvHD was 49.6 for VOR vs 37.6 days for ITR (P=0.067).’ However, the sentence should correctly read:
‘Mean time to first report of GvHD was 127.8 for VOR vs 85.2 days for ITR (P=0.823).’
The authors would like to apologize for any confusion this may have caused.
Author information
Consortia
Additional information
The online version of the original article can be found at 10.1038/bmt.2010.41
Rights and permissions
About this article
Cite this article
Marks, D., Kibbler, C., Cook, G. et al. Erratum: Voriconazole or itraconazole for antifungal prophylaxis in patients with grade II-IV acute or extensive chronic graft-versus-host disease. Bone Marrow Transplant 45, 1578 (2010). https://doi.org/10.1038/bmt.2010.215
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2010.215